
Piprasia-TZ 4.5 Injection
Marketer
Asiatic Pharmaceuticals
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Piprasia-TZ 4.5 Injection
Ceftazidime and Tazobactam injection (Piprasia-TZ 4.5) combines two antibiotics to combat diverse bacterial infections by eliminating the infectious agents. Administration should always be by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity, adhering strictly to their prescribed regimen. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, inform your doctor of any antibiotic allergies, kidney, or liver conditions; adjustments to dosage or alternative medications may be necessary. While generally safe during pregnancy and lactation under medical guidance, consult your physician before use.
Primary Ingredients of Piprasia-TZ 4.5 Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Piprasia-TZ 4.5 Injection
Infections caused by bacteria
Major Benefits of Piprasia-TZ 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Piprasia-TZ 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Piprasia-TZ 4.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Piprasia-TZ 4.5 Injection works:
Piprasia-TZ 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. The addition of Tazobactum counteracts bacterial resistance mechanisms, thus bolstering Piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Piprasia-TZ 4.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Piprasia-TZ 4.5 is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Piprasia-TZ 4.5 Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Piprasia-TZ 4.5 Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administering Piprasia-TZ 4.5 Injection requires careful consideration. Dosage modification of Piprasia-TZ 4.5 Injection might be necessary. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Piprasia-TZ 4.5 Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Piprasia-TZ 4.5 Injection :
Omit one Piprasia-TZ 4.5 Injection dose? Seek your physician's advice.
Facts to Know About Piprasia-TZ 4.5 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Drugs combating infection |
